|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Goodwill and intangible assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current portion of long-term debt and finance lease obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Deferred revenue and customer advances | ||||||||||||||||||||
| Current portion of deferred revenue and customer advances | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term deferred revenue and customer advances | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued pension | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Preferred stock, par value $0.01; Authorized - 5,000,000 shares Series A 6.375% Mandatory Convertible; $250 per share liquidation preference of $693.8 million in the aggregate; Issued and outstanding - 2,760,000 shares (2024: nil) | ||||||||||||||||||||
| 6.375% Series A Mandatory Convertible Preferred Stock | ||||||||||||||||||||
| Total preferred stock, par value $0.01; Authorized - 5,000,000 shares Series A 6.375% Mandatory Convertible; $250 per share liquidation preference of $693.8 million in the aggregate; Issued and outstanding - 2,760,000 shares (2024: nil) | ||||||||||||||||||||
| Common stock, $0.01 par value 260,000,000 shares authorized, 182,456,831 and 175,943,705 shares issued and 151,677,952 and 145,164,826 outstanding at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Common stock, par value $0.01; Authorized - 260,000,000 shares Issued - 183,047,629 shares (2024: 182,456,831); Outstanding - 152,143,041 shares (2024: 151,677,952) | ||||||||||||||||||||
| Treasury stock, at cost Purchased - 30,904,588 shares (2024: 30,778,879) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Other shareholders' equity | ||||||||||||||||||||
| Total shareholders' equity attributable to Bruker Corporation | ||||||||||||||||||||
| Noncontrolling interests in consolidated subsidiaries | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests and shareholders' equity | ||||||||||||||||||||
Loading...
